Lotus Eye Hospital And Institute Ltd - 532998 - Shareholding for the Period Ended December 31, 2020
Lotus Eye Hospital And Institute Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here Lotus Eye Hospital And Institute Ltd - 532998 - Board Meeting Intimation for O Inter Alia Consider And Approve Un-Audited Financial Results For The Quarter Ended 31St December, 2020;
Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2021 ,inter alia, to consider and approve o inter alia consider and approve Un-Audited Financial Results for the Quarter ended 31st December, 2020; Lotus Eye Hospital And Institute Ltd - 532998 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Aakanksha ParmarDesignation :- Company Secretary and Compliance Officer Lotus Eye Hospital And Institute Ltd - 532998 - Appointment Of Dr. S. Natesan As Additional (Non-Executive Independent) Director.
In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors have passed a circular resolution today, i.e. on January 02, 2020, approving appointment of Dr. S. Natesan (DIN:09012904) as an 'Additional Director (Non-Executive Independent Director)' on the Board of Directors of the Company with effect from January 02, 2021 for a term of 5 (five) years upto January 01, 2026, subject to approval of the Shareholders of the Company. Lotus Eye Hospital And Institute Ltd - 532998 - Discloure Of Related Party Trasanction Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And SEBI (Prohibition Of Insider Trading) Regulations, 2015
Discloure of Related Party Trasanction pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI (Prohibition of Insider Trading) Regulations, 2015 Lotus Eye Hospital And Institute Ltd - 532998 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Lotus Eye Hospital And Institute Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Lotus Eye Hospital And Institute Ltd - 532998 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
The proceedings of the 23rd Annual General Meeting along with Scrutinizer''s Report. Lotus Eye Hospital And Institute Ltd - 532998 - Announcement Under Regulation 30 - Error In Uploading Of Full Results Regarding.
Announcement under Regulation 30 - Error in uploading of full results regarding. Lotus Eye Hospital And Institute Ltd - 532998 - Appointment Of Chief Financial Officer
Appointment of Chief Financial Officer Lotus Eye Hospital And Institute Ltd - 532998 - Outcome Of Board Meeting - Appointment Of Dr. Kavetha Sundaramoorthy As The Chairman Of The Company.
Outcome of Board Meeting - Appointment of Dr. Kavetha Sundaramoorthy as the Chairman of the Company.